Nuvation Bio Inc. Class A Common Stock vs Ondas Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.74B), while Ondas Inc. Common Stock trades at $6.72 (market cap $3.99B). The key difference: Ondas Inc. Common Stock is far larger — about 2.3× Nuvation Bio Inc. Class A Common Stock's market cap, and Ondas Inc. Common Stock is more actively traded (60,542,247 versus 9,289,619). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Ondas Inc. Common Stock for 0 Days on average.
| NUVB | ONDS | |
|---|---|---|
Market Cap | $1.74B | $3.99B |
Volume | 9,289,619 | 60,542,247 |
Sector | Health | Technology |
52-Week High | $9.54 | $14.01 |
52-Week Low | $3.41 | $5.25 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.33B | $2.62B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Ondas provides autonomous systems and private wireless solutions through its Ondas Autonomous Systems, Ondas Capital, and Ondas Networks business units. Its technologies combine aerial intelligence and next-generation connectivity for essential industries.
Read more on ONDS →